Nga Ahuatanga Mahinga
Tepe Rapu: 5ng/mL ;
Awhe Raina: 5.00～400.00 ng/mL;
Ko te whakarea hononga raina R ≥0.990;
Tika: i roto i te puranga CV ko ≤15%;i waenganui i nga puranga CV ko ≤20%;
Tika: ko te inenga o nga hua inenga kia kaua e neke ake i te ± 15% ina whakamatauria te kaitauira tika.
1. Whakaorangia te kaitarai i te 2～30 ℃.Ka noho pumau te kaitapa ki te 18 marama.
2. Whakaorangia te rīpene whakamātautau Aehealth Ferritin Rapid Quantitative i te 2～30 ℃, ka eke ki te 18 marama.
3. Me whakamahi rīpene whakamātautau i roto i te 1 haora i muri i te whakatuwheratanga o te mōkihi.
Ko ST2 he mema o te Toll-like receptor/interleukin-1 (interleukin-1, IL-1) receptor superfamily.Ko te IL-33 tana ligand mahi motuhake, ka hunahia e te cardiomyocytes me te fibroblasts.E rua nga hua o te whakaaturanga ira: transmembrane ST2 (ST2L) me te sST2.Kei roto i te ST2L e toru nga waahi immunoglobulin extracellular, i te mea ko te sST2 kaore he rohe whakawhiti me nga rohe whakawhiwhinga intracellular.Ka herea ki te ligand noa IL-33 me te whai waahi koiora.Ko te ara tohu tohu ST2L me te IL-33 he paanga mate ngakau penei i te hypertrophy anti-cardiomyocyte, myocardial fibrosis me te anti-atherosclerosis.Ka piki ake te taumaha o te ngakau, ka piki te hunanga o te sST2, ka aukati te sST2 nui ake i te IL-33 mai i te whakakotahi me te ST2L, na reira ka aukati i te huanga cardioprotective o te ara tohu tohu IL-33/ST2L.E kiia ana ko te sST2 he takawaenga pathogenic o te hypertrophy cardiomyocyte me te fibrosis myocardial.Ko te whakatau inenga o nga taumata sST2 ka taea e nga taakuta he taputapu tika hei awhina i te aromatawai o te ngoikore o te ngakau.